Audrey Bellesœur

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Diane Damotte, Sarah Warren, Jennifer Arrondeau et al. · Journal of Translational Medicine · 2019 · 150 citations · Full text

Medicine, Immunology, Oncology +17

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area

Perrine Vuagnat, Maxime Frélaut, Toulsie Ramtohul et al. · Breast Cancer Research · 2020 · 125 citations · Full text

Medicine, Oncology, Radiology +12

Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients

Rafael Reis, Laurence Labat, Marie Allard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 64 citations

Medicine, Oncology, Pharmacology +15

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

Clémence Basse, Sarah Diakite, Vincent Servois et al. · JNCI Cancer Spectrum · 2020 · 60 citations · Full text

Medicine, Infectious Diseases, Molecular Oncology +10

The impact of body composition parameters on severe toxicity of nivolumab

Laure Hirsch, Audrey Bellesœur, Pascaline Boudou‐Rouquette et al. · European Journal of Cancer · 2019 · 42 citations

Pharmacy, Pharmacology, Pharmacotherapy +8